Akses terbuka
Jurnal
SINTA 1
The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast
Indonesian Journal of Biotechnology · Vol. 27 No. 3 (2022) · hlm. 126–132
ISSN 2089-2241, 0853-8654
Terbit 2022-09-30
Penerbit Universitas Gadjah Mada
Bahasa eng
Abstrak
Keloid is a benign fibroproliferative tissue growth that exceeds the initial wound margins. Captopril has been tested in vitro to reduce fibroblast proliferation and collagen deposition; thus, it has potential for use in the treatment of keloids. Meanwhile, 5‐fluorouracil (5‐FU) has already been used in keloid management. This study aimed to determine the efficacy of the combination of captopril and 5‐FU in keloid fibroblast cultures. Keloid tissues were cultured up to passages 4–7. The study consisted of a control group, captopril in various concentrations (10‐2, 10‐3, 10‐4, and 10‐5 mol/L), 5‐FU 1 mg/mL and a combination of captopril at various concentrations with 5‐FU 1 mg/mL. After 144 hours of treatment, fibroblast proliferation and collagen deposition were measured. The study showed a significant decrease in the mean index of fibroblast proliferation and collagen deposition in the group receiving captopril in various concentrations (10‐2, 10‐3, 10‐4, and 10‐5 mol/L) and the 5‐FU group against the control group (p<0.05). In the combined‐dose group, captopril at a concentration of 10‐2 mol/L and 5‐FU showed a significant reduction in fibroblast proliferation and collagen deposition compared to the 5‐FU group and the captopril at the same dose (p<0.05). In conclusion, the combination of captopril 10‐2 mol/L and 5‐FU 1 mg/mL is better at reducing fibroblast proliferation and collagen deposition in keloid fibroblast cultures than captopril or 5‐FU as a single therapeutic agent.
Jaringan kolaborasi para penulis
25 penulis ·
76 tautan kepenulisan bersama
· 10 lintas organisasi
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
Universitas Gadjah Mada Rumah Sakit Umum Pusat Dr. Sardjito Islamic University of Indonesia Afiliasi tidak diketahui
Organisasi berbeda
Organisasi sama
Afiliasi tidak diketahui
Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.
Sumber metadata: OAI-PMH (metadata jurnal) https://jurnal.ugm.ac.id/ijbiotech/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title xml:lang="en-US">The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast</dc:title>
<dc:creator>Amelia, Jesslyn</dc:creator>
<dc:creator>Wirohadidjojo, Yohanes Widodo</dc:creator>
<dc:creator>Siswati, Agnes Sri</dc:creator>
<dc:subject xml:lang="en-US">5‐fluorouracil; captopril; collagen deposition; fibroblast proliferation; keloid fibroblast</dc:subject>
<dc:description xml:lang="en-US">Keloid is a benign fibroproliferative tissue growth that exceeds the initial wound margins. Captopril has been tested in vitro to reduce fibroblast proliferation and collagen deposition; thus, it has potential for use in the treatment of keloids. Meanwhile, 5‐fluorouracil (5‐FU) has already been used in keloid management. This study aimed to determine the efficacy of the combination of captopril and 5‐FU in keloid fibroblast cultures. Keloid tissues were cultured up to passages 4–7. The study consisted of a control group, captopril in various concentrations (10‐2, 10‐3, 10‐4, and 10‐5 mol/L), 5‐FU 1 mg/mL and a combination of captopril at various concentrations with 5‐FU 1 mg/mL. After 144 hours of treatment, fibroblast proliferation and collagen deposition were measured. The study showed a significant decrease in the mean index of fibroblast proliferation and collagen deposition in the group receiving captopril in various concentrations (10‐2, 10‐3, 10‐4, and 10‐5 mol/L) and the 5‐FU group against the control group (p<0.05). In the combined‐dose group, captopril at a concentration of 10‐2 mol/L and 5‐FU showed a significant reduction in fibroblast proliferation and collagen deposition compared to the 5‐FU group and the captopril at the same dose (p<0.05). In conclusion, the combination of captopril 10‐2 mol/L and 5‐FU 1 mg/mL is better at reducing fibroblast proliferation and collagen deposition in keloid fibroblast cultures than captopril or 5‐FU as a single therapeutic agent.</dc:description>
<dc:publisher xml:lang="en-US">Universitas Gadjah Mada</dc:publisher>
<dc:contributor xml:lang="en-US">Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta</dc:contributor>
<dc:date>2022-09-30</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:type xml:lang="en-US">Original Research Articles</dc:type>
<dc:format>application/pdf</dc:format>
<dc:identifier>https://journal.ugm.ac.id/ijbiotech/article/view/69505</dc:identifier>
<dc:identifier>10.22146/ijbiotech.69505</dc:identifier>
<dc:source xml:lang="en-US">Indonesian Journal of Biotechnology; Vol 27, No 3 (2022); 126-132</dc:source>
<dc:source>2089-2241</dc:source>
<dc:source>0853-8654</dc:source>
<dc:language>eng</dc:language>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/view/69505/34715</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18613</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18614</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18615</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18616</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18617</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18618</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18619</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18620</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18621</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18622</dc:relation>
<dc:relation>https://journal.ugm.ac.id/ijbiotech/article/downloadSuppFile/69505/18623</dc:relation>
<dc:rights xml:lang="en-US">Copyright (c) 2022 The Author(s)</dc:rights>
<dc:rights xml:lang="en-US">http://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>
Sitasi dan pengindeksan
Jumlah menurut tiap indeks pada 13 Nov 2026; setiap indeks menghitung sitasi dengan cara berbeda.
OpenAlex juga mencatat karya ini di: crossref, doaj.
Sitasi artikel ini
APA 7
Amelia, J., Wirohadidjojo, Y. W., & Siswati, A. S. (2022). The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast. Indonesian Journal of Biotechnology, 27(3), 126–132. https://doi.org/10.22146/ijbiotech.69505
Salin
IEEE
J. Amelia, Y. W. Wirohadidjojo, and A. S. Siswati, “The efficacy of captopril and 5-fluorouracil combination in the proliferation and collagen deposition of keloid fibroblast,” Indonesian Journal of Biotechnology, vol. 27, no. 3, pp. 126–132, 2022, doi: 10.22146/ijbiotech.69505.
Salin
Dibuat dari metadata jurnal; periksa nama penulis sebelum dipakai.